We narrowed to 9,625 results for: try

#81872

Gateway Donor vector containing MZT1 , part of the Target Accelerator Plasmid Collection.

Jesse Boehm, William Hahn, David Root

Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

April 24, 2017

Academic Institutions and Nonprofits only

#246738

Mammalian expression of human CHIP with U-box domain deleted, and a myc-tag on its C-terminus

Yihong Ye

Lee et al Nat Cell Biol. 2025 Aug 25. doi: 10.1038

Dec. 2, 2025

Academic Institutions and Nonprofits only

#242564

Gateway middle entry clone containing an EGFP fused to the human microRNA 126.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Oct. 1, 2025

Academic Institutions and Nonprofits only

#242563

Gateway middle entry clone containing an EGFP fused to the murine microRNA 500.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Oct. 1, 2025

Academic Institutions and Nonprofits only

#242559

Gateway middle entry clone containing a zebrafish FUCCI reporter followed by H2A tdiRFP reporter; For visualizing cell cycle state.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 22, 2025

Academic Institutions and Nonprofits only

#238968

Mammalian neurons HyPer7 expression targeted to the mitochondrial matrix

Dmitry Bilan

Kelmanson et al Redox Biol. 2021 Nov 3;48:102178. doi: 1

Aug. 15, 2025

Academic Institutions and Nonprofits only

#238972

Mammalian neurons SypHer3s expression targeted to the mitochondrial matrix

Dmitry Bilan

Kelmanson et al Redox Biol. 2021 Nov 3;48:102178. doi: 1

Aug. 4, 2025

Academic Institutions and Nonprofits only

#224474

Gateway compatible 5' entry clone with human alpha 2 globin pause site (to prevent transcription readthrough) and EF1a core promoter. Lacks downstream intron for a lower-activity, compact promoter.

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 30, 2024

Academic Institutions and Nonprofits only

#224505

Gateway compatible middle entry clone containing a Destablized LexA and LexOperon with minimal CaMV 35S promoter as an all in one casette for RU486 driven gene expression

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 27, 2024

Academic Institutions and Nonprofits only

#224506

Gateway compatible middle entry clone containing a Destablized LexA and LexOperon with 3' minimal c-Fos promoter for an all in one RU486 driven gene expression construct

Joshua Wythe

Gillespie WB et al Development. 2025 Nov 15;152(22):dev2043

Sept. 27, 2024

Academic Institutions and Nonprofits only